文献速递心血管胸部CTDSA

双源CT检测心脏移植受者心脏移植物血管病变:与有创冠状动脉造影的比较

Detection of cardiac allograft vasculopathy on dual source computed tomography in heart transplant recipients: comparison with invasive coronary angiography.
PubMed 文献 · Br J Radiol · 2022-03-08

连续38例心脏移植受者年度监测中先行双源CT冠状动脉造影(DSCTCA)再行有创冠状动脉造影(ICA),以ICA为参考评估狭窄性心脏移植物血管病变(CAV)。患者水平DSCTCA检测任何CAV和显著CAV的敏感度均为100%,特异度分别为91.3%和94%,阴性预测值均为100%。作者认为DSCTCA高敏感度和高阴性预测值提示其可作为ICA的准确无创替代方法用于常规监测。

要点

  • 患者水平DSCTCA检测任何CAV敏感度100%、特异度91.3%、阴性预测值100%、诊断准确率94.73%。
  • 患者水平DSCTCA检测显著CAV(>50%狭窄)敏感度100%、特异度94%、阴性预测值100%、诊断准确率95%。
  • 两种方法检测任何CAV和显著CAV的Kappa值分别为0.892和0.826(患者水平)。

核心结论

  • DSCTCA评估狭窄性CAV具有高敏感度和高阴性预测值,提示其可作为ICA的准确无创替代方法用于心脏移植受者的常规监测。

研究设计与样本

  • 连续38例心脏移植受者年度监测中,于ICA前使用192探测器384层双源CT行DSCTCA,以ICA为参考标准,将病例分为无CAV(无狭窄)、任何CAV(任何程度狭窄)或显著CAV(>50%狭窄)。

关键影像表现/征象

  • DSCTCA上任何CAV和显著CAV的患病率分别为44.7%(n=17)和21.1%(n=8),ICA上分别为39.5%(n=15)和15.8%(n=6)。
  • DSCTCA上557个(96.7%)节段可判读。
  • 两方法检测任何CAV和显著CAV的Kappa值分别为0.892和0.826(患者水平)、0.859和0.927(节段水平)。
  • 冠状动脉钙化积分在两种方法上均与任何CAV的存在显著相关。
  • 活检诊断的排斥反应与DSCTCA或ICA上的任何/显著CAV不相关。

诊断标准与关键数值

  • 患者水平DSCTCA检测任何CAV的敏感度100%、特异度91.3%、阳性预测值88.2%、阴性预测值100%、诊断准确率94.73%。
  • 患者水平DSCTCA检测显著CAV(>50%狭窄)的敏感度100%、特异度94%、阳性预测值75%、阴性预测值100%、诊断准确率95%。
  • 节段水平DSCTCA检测任何CAV的敏感度96%、特异度97.6%、阳性预测值80%、阴性预测值99.6%、诊断准确率97.5%。
  • 节段水平DSCTCA检测显著CAV的敏感度100%、特异度99.6%、阳性预测值86.7%、阴性预测值100%、诊断准确率99.6%。

临床应用与阅片要点

  • DSCTCA平均辐射剂量为4.24±2.15 mSv,作者认为其以较低辐射剂量实现与导管冠状动脉造影高度一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: We aimed to evaluate the diagnostic accuracy (DA) of dual-source CT coronary angiography (DSCTCA) against invasive coronary angiography (ICA) in assessing stenotic cardiac allograft vasculopathy (CAV) in heart transplant (HTX) recipients.

METHODS: Consecutive HTX recipients(n = 38) on annual surveillance, underwent DSCTCA prior to ICA on a 192-detector 384-slice DSCT scanner. Cases were classified as no CAV (no stenosis), any CAV (any degree of stenosis) or significant CAV (>50% stenosis).

RESULTS: Mean age was 33.66 ± 11.45 years (M:F = 27:11, median time from HTX-23.5 months). Prevalence of any CAV on DSCTCA and ICA was 44.7%(n = 17) and 39.5%(n = 15), respectively and that of significant CAV was 21.1%(n = 8) and 15.8%(n = 6), respectively. 557 (96.7%) segments were interpretable on DSCTCA. Mean radiation dose was 4.24 ± 2.15 mSv. At patient-level, the sensitivity, specificity, positive-predictive value, negative-predictive value (NPV), and DA of DSCTCA for detection of any CAV and significant CAV were 100%, 91.3%, 88.2%, 100%, 94.73% and 100%, 94%, 75%, 100%, 95% respectively. The same on segment-based analysis were 96%, 97.6%, 80%, 99.6%, 97.5% and 100%, 99.6%,86.7%,100%, 99.6%, respectively. There was excellent agreement between the two modalities for detection of any CAV and significant CAV [κ = 0.892 and 0.826 (patient-level), 0.859 and 0.927 (segment-level)]. CAC score correlated significantly with the presence of any CAV on both modalities. A diagnosis of rejection on biopsy did not correlate with any/significant CAV on DSCTCA or ICA.

CONCLUSION: High sensitivity and NPV of DSCTCA in the evaluation of stenotic CAV suggests that it can be an accurate and non-invasive alternative to ICA for routine surveillance of HTX recipients.

ADVANCES IN KNOWLEDGE: DSCTCA detects the stenotic CAV non-invasively in transplant recipients with high sensitivity, specificity and NPV when compared with catheter coronary angiography, at lower radiation doses. There is excellent agreement between CT angiography and catheter coronary angiography for detection of any CAV and significant CAV. A diagnosis of rejection on biopsy does not correlate with any/significant CAV on CT angiography or catheter angiography.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ojha, Ganga, Mani, et al. Detection of cardiac allograft vasculopathy on dual source computed tomography in heart transplant recipients: comparison with invasive coronary angiography. Br J Radiol. 2022. PMID: 35230144. doi:10.1259/bjr.20211237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。